Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Feb. 4, 2022

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

Feb. 4, 2022

Researchers present preclinical model of ALS

Feb. 4, 2022

Meta-analysis reveals candidate variants associated with brain traits

Feb. 4, 2022

Co-stimulation with CD81 promotes CAR T-cell transduction toward naive T cells

Feb. 4, 2022

Deep immunophenotyping study characterizes advanced immune aging in individuals with Down syndrome

Feb. 4, 2022

Anakuria's AT-20494 to be studied for ADPKD and other indications

Feb. 3, 2022

Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases

Feb. 3, 2022

CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1

Feb. 3, 2022

PLA2-IIA modulates immunity through its interaction with microbiota

Feb. 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...